| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CDO1 mRNA | CTD | PMID:17108234 |
| 17beta-estradiol | decreases expression | ISO | RGD:737394 | 6480464 | Estradiol results in decreased expression of CDO1 mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | affects expression | ISO | RGD:737395 | 6480464 | Estradiol affects the expression of CDO1 mRNA | CTD | PMID:16684588 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:737395 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA]; more ... | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDO1 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDO1 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CDO1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDO1 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737395 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDO1 mRNA | CTD | PMID:16054899 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDO1 mRNA | CTD | PMID:18465118 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737395 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDO1 mRNA | CTD | PMID:15667827 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDO1 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737395 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDO1 mRNA | CTD | PMID:15667827 PMID:16054899 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:737395 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA; more ... | CTD | PMID:16054899 |
| 6-propyl-2-thiouracil | affects expression | EXP | | 6480464 | Propylthiouracil affects the expression of CDO1 mRNA | CTD | PMID:19483382 |
| aflatoxin B1 | affects expression | ISO | RGD:737394 | 6480464 | Aflatoxin B1 affects the expression of CDO1 protein | CTD | PMID:20106945 |
| amiodarone | affects expression | EXP | | 6480464 | Amiodarone affects the expression of CDO1 mRNA | CTD | PMID:19483382 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CDO1 mRNA | CTD | PMID:16483693 |
| Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CDO1 mRNA | CTD | PMID:18178546 |
| arsenite(3-) | decreases expression | ISO | RGD:737395 | 6480464 | arsenite results in decreased expression of CDO1 mRNA | CTD | PMID:18191166 |
| benzbromarone | affects expression | EXP | | 6480464 | Benzbromarone affects the expression of CDO1 mRNA | CTD | PMID:19483382 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:737395 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of CDO1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:737394 | 6480464 | Benzo(a)pyrene results in decreased expression of CDO1 mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CDO1 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | decreases expression | ISO | RGD:737395 | 6480464 | Benzo(a)pyrene results in decreased expression of CDO1 mRNA | CTD | PMID:19770486 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:737394 | 6480464 | Diethylhexyl Phthalate results in decreased expression of CDO1 mRNA | CTD | PMID:16223563 |
| bromobenzene | decreases expression | EXP | | 6480464 | bromobenzene results in decreased expression of CDO1 mRNA | CTD | PMID:12628495 |
| bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of CDO1 mRNA | CTD | PMID:15056800 |
| chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of CDO1 mRNA | CTD | PMID:23125180 |
| choline | multiple interactions | ISO | RGD:737395 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDO1 gene | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:737395 | 6480464 | Ciguatoxins affects the expression of CDO1 mRNA | CTD | PMID:18353800 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CDO1 mRNA | CTD | PMID:18246545 |
| clofibrate | affects expression | EXP | | 6480464 | Clofibrate affects the expression of CDO1 mRNA | CTD | PMID:19483382 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of CDO1 mRNA | CTD | PMID:17602206 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of CDO1 mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of CDO1 mRNA | CTD | PMID:22465980 |
| corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of CDO1 mRNA | CTD | PMID:15755911 |
| coumarin | affects expression | EXP | | 6480464 | coumarin affects the expression of CDO1 mRNA | CTD | PMID:16963487 |
| cyclosporin A | decreases expression | ISO | RGD:737394 | 6480464 | Cyclosporine results in decreased expression of CDO1 mRNA | CTD | PMID:20106945 |
| dexamethasone | multiple interactions | ISO | RGD:737395 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA; more ... | CTD | PMID:16054899 |
| diazoxide | increases expression | ISO | RGD:737395 | 6480464 | Isoproterenol results in increased expression of CDO1 mRNA | CTD | PMID:20003209 |
| folic acid | multiple interactions | ISO | RGD:737395 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDO1 gene | CTD | PMID:20938992 |
| iron atom | multiple interactions | EXP | | 6480464 | Iron binds to and results in increased activity of CDO1 protein | CTD | PMID:16611640 |
| isoprenaline | increases expression | ISO | RGD:737395 | 6480464 | Isoproterenol results in increased expression of CDO1 mRNA | CTD | PMID:20003209 |
| L-ethionine | affects expression | EXP | | 6480464 | Ethionine affects the expression of CDO1 mRNA | CTD | PMID:19483382 |
| L-methionine | multiple interactions | ISO | RGD:737395 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDO1 gene | CTD | PMID:20938992 |
| m-xylene | decreases expression | EXP | | 6480464 | 3-xylene results in decreased expression of CDO1 mRNA | CTD | PMID:12815608 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of CDO1 mRNA | CTD | PMID:16809437 |
| N-methyl-4-phenylpyridinium | decreases expression | ISO | RGD:737395 | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of CDO1 mRNA | CTD | PMID:17475336 PMID:18069091 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of CDO1 mRNA | CTD | PMID:17072980 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of CDO1 mRNA | CTD | PMID:18417182 |
| omeprazole | affects expression | EXP | | 6480464 | Omeprazole affects the expression of CDO1 mRNA | CTD | PMID:19483382 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CDO1 mRNA | CTD | PMID:19103213 |
| paracetamol | increases expression | ISO | RGD:737394 | 6480464 | Acetaminophen results in increased expression of CDO1 mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | ISO | RGD:737395 | 6480464 | Acetaminophen affects the expression of CDO1 mRNA | CTD | PMID:17562736 |
| paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of CDO1 mRNA | CTD | PMID:16854511 |
| perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CDO1 mRNA | CTD | PMID:18692542 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CDO1 mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | affects expression | ISO | RGD:737395 | 6480464 | perfluorooctanoic acid affects the expression of CDO1 mRNA | CTD | PMID:18281256 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CDO1 mRNA | CTD | PMID:19162173 |
| piperonyl butoxide | decreases expression | EXP | | 6480464 | Piperonyl Butoxide results in decreased expression of CDO1 mRNA | CTD | PMID:22484513 |
| pirinixic acid | multiple interactions | ISO | RGD:737394 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CDO1 mRNA | CTD | PMID:19710929 |
| pirinixic acid | affects expression | EXP | | 6480464 | pirinixic acid affects the expression of CDO1 mRNA | CTD | PMID:19483382 |
| pirinixic acid | decreases expression | ISO | RGD:737395 | 6480464 | pirinixic acid results in decreased expression of CDO1 mRNA | CTD | PMID:20813756 |
| pirinixic acid | multiple interactions | ISO | RGD:737395 | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of CDO1 mRNA | CTD | PMID:20813756 |
| pirinixic acid | multiple interactions | ISO | RGD:737395 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CDO1 mRNA | CTD | PMID:19710929 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CDO1 mRNA | CTD | PMID:19162173 |
| progesterone | affects expression | ISO | RGD:737395 | 6480464 | Progesterone affects the expression of CDO1 mRNA | CTD | PMID:17251523 |
| quercetin | decreases expression | ISO | RGD:737394 | 6480464 | Quercetin results in decreased expression of CDO1 mRNA | CTD | PMID:21632981 |
| quinolin-8-ol | decreases expression | ISO | RGD:737394 | 6480464 | Oxyquinoline results in decreased expression of CDO1 mRNA | CTD | PMID:21632981 |
| raloxifene | multiple interactions | ISO | RGD:737394 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in increased expression of CDO1 mRNA | CTD | PMID:19059307 |
| rosiglitazone | multiple interactions | ISO | RGD:737395 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CDO1 mRNA; more ... | CTD | PMID:16054899 |
| tamoxifen | multiple interactions | ISO | RGD:737394 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of CDO1 mRNA | CTD | PMID:19059307 |
| tetrachloromethane | increases expression | ISO | RGD:737395 | 6480464 | Carbon Tetrachloride results in increased expression of CDO1 mRNA | CTD | PMID:17484886 |
| thioacetamide | affects expression | EXP | | 6480464 | Thioacetamide affects the expression of CDO1 mRNA | CTD | PMID:19483382 |